We are live on ! Find out more
TOVX icon

Theriva Biologics

18 hedge funds and large institutions have $573K invested in Theriva Biologics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

230% more capital inflows, than outflows

Capital inflows: $44.9K | Capital outflows: $13.6K

20% more funds holding

Funds holding: 15 → 18 (+3)

0.43% less ownership

Funds ownership: 6.66% → 6.24% (-0.43%)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TOVX Hedge Fund Activity: Q3 2023 in Review

18 of the 6,318 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q3 2023, worth a combined $573K — down 43% from $1.01M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TOVX positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $15.1K. The largest seller was Vanguard Group, cutting an estimated $7.66K.

  • 18 institutional investors held Theriva Biologics (TOVX) as of Q3 2023, up from 15 in Q2 2023.
  • Funds reported $573K of Theriva Biologics stock for Q3 2023, down 43% quarter-over-quarter.
  • 4 funds opened new Theriva Biologics positions in Q3 2023 and 1 closed out, a net change of +3 holders.
  • The largest Theriva Biologics buyer in Q3 2023 was Geode Capital Management, an estimated $15.1K added.
  • The largest Theriva Biologics seller in Q3 2023 was Vanguard Group, an estimated $7.66K sold.

Based on aggregated 13F filings for Q3 2023.